• A case of ulcerative colitis with a variety of autoimmune diseases including ankylosing spondylitis, type 2 autoimmune pancreatitis, and primary sclerosing cholangitis
• A case report of immune checkpoint inhibitor-related myositis and cholangitis induced by pembrolizumab
• A Rare Cause of Hepatic Mass With High Metabolic Activity and Jaundice
• Acquired ductopenia: an insight into imaging findings
• Additional Yield of Random Biopsy in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
• An 'Adaptive Treatment Strategy' for Oral Vancomycin in Patients with the Orphan Disease Primary Sclerosing Cholangitis
• An analysis of related factors in thrombocytopenia combined with cirrhosis: a cross-sectional study of 2 517 cases
• Antimicrobial glycoprotein 2 (GP2) in gallstones, bile fluid and peribiliary glands of patients with primary sclerosing cholangitis
• Assessment of disease severity with magnetic resonance cholangiography in pediatric-onset primary sclerosing cholangitis
• Autoimmune diseases and COPD risk: A Mendelian randomization study
• Caregiver-reported symptom burden and preferences for therapeutic goals in pediatric primary sclerosing cholangitis
• Causal effects of autoimmune diseases on temporomandibular disorders and the mediating pathways: a Mendelian randomization study
• Causal relationship between primary sclerosing cholangitis and systemic lupus erythematosus: a bidirectional Mendelian randomization study
• Causality of immune cells on primary sclerosing cholangitis: a bidirectional two-sample Mendelian randomization study
• Causality of metabolites and metabolic pathways on cholestatic liver diseases: a Mendelian randomization study
• Cilofexor in Patients With Compensated Cirrhosis Due to Primary Sclerosing Cholangitis: An Open-Label Phase 1B Study
• Clinical outcomes and reintervention after endoscopic retrograde cholangiopancreatography in primary sclerosing cholangitis in absence of cholangitis
• Comparing animal well-being between bile duct ligation models
• Comparing the adverse effects of ketamine and esketamine between genders using FAERS data
• Diagnosis of isolated hilar-/extrahepatic-type IgG-4-related sclerosing cholangitis can be increased by improved recognition of this condition-A Japanese multicenter analysis
• Diagnosis of isolated IgG4-related sclerosing cholangitis in perinatal: A case report
• Diagnostic Accuracy of Transient Elastography for Staging Liver Fibrosis in Autoimmune Liver Diseases: A Systematic Review and Meta-Analysis
• Disease severity prognostication in primary sclerosing cholangitis: a validation of the Anali scores and comparison with the potential functional stricture
• Dissecting the causal role of immunophenotypes in primary sclerosing cholangitis risk: A Mendelian randomization study
• Distinct metabolomic and lipidomic profiles in serum samples of patients with primary sclerosing cholangitis
• Does Timing of Ileal Pouch-Anal Anastomosis Matter in Patients With Primary Sclerosing Cholangitis and Orthotopic Liver Transplantation? A Systematic Review and Meta-analysis
• Drug induced cholestatic liver diseases
• Dysplasia Detected in Patients With Serrated Epithelial Change Is Frequently Associated With an Invisible or Flat Endoscopic Appearance, Nonconventional Dysplastic Features, and Advanced Neoplasia
• Easy recognition and high autoimmune hepatitis specificity of smooth muscle antibodies giving an actin microfilament immunofluorescent pattern on embryonal vascular smooth muscle cells
• Effect of dominant stricture and disease duration on prognosis in primary sclerosing cholangitis
• Elafibranor: First Approval
• Endoscopic Characterization and Outcome of COVID-19 Patients with Secondary Sclerosing Cholangitis: A Case Series of a Tertiary Center
• Endoscopic Retrograde Cholangiopancreatography-Related Procedures for the Differential Diagnosis of Isolated Immunoglobin G4-Related Sclerosing Cholangitis and Perihilar Cholangiocarcinoma
• Epigenetic disease markers in primary sclerosing cholangitis and primary biliary cholangitis-methylomics of cholestatic liver disease
• Evaluation of four chatbots in autoimmune liver disease: A comparative analysis
• Exploring the Pathogenesis of Autoimmune Liver Diseases from the Heterogeneity of Target Cells
• Farnesoid X Receptor Agonists: A Promising Therapeutic Strategy for Gastrointestinal Diseases
• Fatigue is a symptom of clinical importance in patients with Primary Sclerosing Cholangitis (SOMA.LIV)
• Frequency, spectrum and outcome of patients with primary sclerosing cholangitis among patients presenting with cholestatic jaundice
• Good long-term outcomes of primary sclerosing cholangitis in childhood
• GSK805 inhibits alpha-smooth muscle expression and modulates liver inflammation without impairing the well-being of mice
• Gut Pathobiont-Derived Outer Membrane Vesicles Drive Liver Inflammation and Fibrosis in Primary Sclerosing Cholangitis-Associated Inflammatory Bowel Disease
• Gut Pathobiont-Derived Outer Membrane Vesicles Drive Liver Inflammation and Fibrosis in PSC-IBD
• Hepatitis and Vasodilatory Shock due to an Unsuspected Culprit: A Rare Presentation of Multisystem Langerhans Cell Histiocytosis
• Histopathological impact of SARS-CoV-2 on the liver: Cellular damage and long-term complications
• Hospitalizations for opportunistic infections following transplantation and associated risk factors: A national cohort study of Medicare beneficiaries
• Human Hepatobiliary Organoids: Recent Advances in Drug Toxicity Verification and Drug Screening
• Idiopathic hyalinizing fibrosclerosis: A systemic steroid-resistant condition distinct from IgG4-related disease
• Ileal pouch-anal anastomosis and end ileostomy result in equivalent graft survival following liver transplantation for inflammatory bowel disease-primary sclerosing cholangitis
• Imaging of Biliary Tree Abnormalities
• Immunological crossroads: The intriguing dance between hepatitis C and autoimmune hepatitis
• Inborn Errors of Immunity in Adults with Autoimmune Liver Diseases
• Inflammatory bowel disease associated with primary sclerosing cholangitis is associated with an altered gut microbiome and bile acid profile
• Intergenic risk variant rs56258221 skews the fate of naive CD4(+) T cells via miR4464-BACH2 interplay in primary sclerosing cholangitis
• Ketamine-Induced Sclerosing Cholangitis Associated With Early Inflammatory Bowel Disease During Chronic Topical Ketamine Use
• Letter: Microbial manipulation for primary sclerosing cholangitis-associated inflammatory bowel disease-hope on the horizon
• Liver diseases in the intensive care unit
• Liver enzyme profiles after initiating biological treatment in children with inflammatory bowel diseases
• Liver Transplantation Profile Among Teenagers in the United States
• Loss of mucosal tolerance to glycoprotein 2 isoform 1 is a potential novel diagnostic biomarker for cholangiocarcinoma
• Loss of β-catenin reveals a role for glutathione in regulating oxidative stress during cholestatic liver disease
• Machine Learning Identifies Key Proteins in Primary Sclerosing Cholangitis Progression and Links High CCL24 to Cirrhosis
• Modulation of miR-155-5p signalling via 5-ASA for the prevention of high microsatellite instability: an in vitro study using human epithelial cell lines
• Network proximity analysis as a theoretical model for identifying potential novel therapies in primary sclerosing cholangitis
• New target-HMGCR inhibitors for the treatment of primary sclerosing cholangitis: A drug Mendelian randomization study
• Obstructive sleep apnea and 19 gastrointestinal diseases: a Mendelian randomization study
• Odevixibat as an adjunctive treatment for refractory pruritus in rare variants of cholestatic liver disease
• Only repeatedly elevated IgG4 levels in primary sclerosing cholangitis may distinguish a particular patient phenotype
• Past, current, and future trends in the prevalence of primary sclerosing cholangitis and inflammatory bowel disease across England (2015-2027): a nationwide, population-based study
• Patient-Reported Outcome Screens for Cognitive Dysfunction and Predicts Admissions in Cirrhosis
• Percutaneous Treatment of Hydatid Cysts with the Örmeci Technique
• PPAR-Mediated Bile Acid Glucuronidation: Therapeutic Targets for the Treatment of Cholestatic Liver Diseases
• Predicting ERCP procedure time - the SWedish Estimation of ERCP Time (SWEET) tool
• Prevalence of stricturing, penetrating complications and extraintestinal manifestations in inflammatory bowel disease detected on cross-sectional imaging in a tertiary care setting
• Preventive Antibiotic Use and Complications After Endoscopic Retrograde Cholangiopancreatography in Patients Hospitalized for Primary Sclerosing Cholangitis
• Primary Sclerosing Cholangitis Associated With Ulcerative Colitis Coexisting With Cholangiocarcinoma: A Case Report
• Primary sclerosing cholangitis with IgG4-positive plasma cells in bile duct biopsies - Frequency and characterization
• Progress in the Management of Patients with Cholestatic Liver Disease: Where Are We and Where Are We Going?
• Protocol for the development of a core outcome set for clinical trials in primary sclerosing cholangitis
• Quantitative Magnetic Resonance Cholangiopancreatography Scoring and Its Predictive Value for Outcomes in Adults with Primary Sclerosing Cholangitis
• Recurrence of Primary Disease After Adult Liver Transplant - Risk Factors, Early Diagnosis, Management, and Prevention
• Response to Letter to the Editor: Tubulin beta is not the target of antineutrophil antibodies in primary sclerosing cholangitis
• RNA-binding protein transcripts as potential biomarkers for detecting Primary Sclerosing Cholangitis and for predicting its progression to Cholangiocarcinoma
• ROS-responsive and biomimetic nanoparticle delivery of obeticholic acid mitigates primary sclerosing cholangitis via mitochondria- induced apoptosis
• ROS-responsive nanoparticle delivery of obeticholic acid mitigate primary sclerosing cholangitis
• Rosacea and autoimmune liver diseases: a two-sample Mendelian randomization study
• Sclerosing cholangitis and inflammatory bowel disease: a paradoxical relationship?
• Serologic extracellular matrix remodeling markers are related to fibrosis stage and prognosis in a phase 2b trial of simtuzumab in patients with primary sclerosing cholangitis
• Severe Cholestasis Predicts Recurrent Primary Sclerosing Cholangitis Following Liver Transplantation
• Single-Cell Transcriptomic Profiling of Cholangiocyte Organoids Derived from Bile Ducts of Primary Sclerosing Cholangitis Patients
• Still elusive: Developments in the accurate diagnosis of indeterminate biliary strictures
• Successful Preoperative Transjugular Intrahepatic Portosystemic Shunt for Portal Decompression in Patients With Inflammatory Bowel Disease and Cirrhosis Requiring Surgical Intervention
• The potential of volatile organic compounds to diagnose primary sclerosing cholangitis
• Total astragalus saponins attenuate primary sclerosing cholangitis in mice by upregulation of TGR5
• Transposon-based oncogene integration in Abcb4(Mdr2)-/- mice recapitulates high susceptibility to cholangiocarcinoma in primary sclerosing cholangitis
• Trends of autoimmune liver disease inpatient hospitalization and mortality from 2011 to 2017: A United States nationwide analysis
• Tubulin beta 5 is not the target of antineutrophil antibodies in primary sclerosing cholangitis
• Untangling biliary reconstruction in liver transplants for primary sclerosing cholangitis
• Whole-exome sequencing reveals novel cancer genes and actionable targets in biliary tract cancers in primary sclerosing cholangitis
• Wits Transplant Unit Annual Report 2022: Adult and paediatric liver transplantation